Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Quality Index
Tianjin Tianyao Pharmaceuticals Co Ltd cash flow quality index. Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow Quality Index of 0.65x as of September 2025. Operating cash flow of CN¥13.19 Million is below net income of CN¥20.24 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Tianjin Tianyao Pharmaceuticals Co Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Cash flow quality index of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. Historical Cash Flow Quality Index for Tianjin Tianyao Pharmaceuticals Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Tianjin Tianyao Pharmaceuticals Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Quality Index by Year (2000–2024)
Tianjin Tianyao Pharmaceuticals Co Ltd cash flow quality index by year from 2000 to 2024. Year-by-year earnings quality comparison for Tianjin Tianyao Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Tianjin Tianyao Pharmaceuticals Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.73x | CN¥569.37 Million | CN¥208.21 Million | ▼ -59.1% |
| 2023 | 6.69x | CN¥783.01 Million | CN¥117.05 Million | ▼ -81.1% |
| 2022 | 35.45x | CN¥653.52 Million | CN¥18.44 Million | ▲ +1115.5% |
| 2021 | 2.92x | CN¥316.89 Million | CN¥108.67 Million | ▼ -32.3% |
| 2020 | 4.31x | CN¥346.88 Million | CN¥80.58 Million | ▲ +182.3% |
| 2019 | 1.52x | CN¥279.37 Million | CN¥183.21 Million | ▲ +58.7% |
| 2018 | 0.96x | CN¥189.27 Million | CN¥196.96 Million | ▲ +2016.3% |
| 2017 | -0.05x | CN¥-8.15 Million | CN¥162.43 Million | ▼ -105.1% |
| 2016 | 0.99x | CN¥63.32 Million | CN¥63.97 Million | ▼ -39.8% |
| 2015 | 1.64x | CN¥129.50 Million | CN¥78.81 Million | ▼ -20.3% |
| 2014 | 2.06x | CN¥178.76 Million | CN¥86.72 Million | ▲ +26.8% |
| 2013 | 1.63x | CN¥84.55 Million | CN¥52.00 Million | ▲ +1116.0% |
| 2012 | 0.13x | CN¥13.23 Million | CN¥98.92 Million | ▼ -83.8% |
| 2011 | 0.82x | CN¥78.47 Million | CN¥95.12 Million | ▼ -34.5% |
| 2010 | 1.26x | CN¥116.82 Million | CN¥92.79 Million | ▼ -80.6% |
| 2009 | 6.49x | CN¥435.13 Million | CN¥67.07 Million | ▲ +52.9% |
| 2008 | 4.24x | CN¥219.31 Million | CN¥51.69 Million | ▼ -26.7% |
| 2007 | 5.79x | CN¥162.33 Million | CN¥28.04 Million | ▲ +412.1% |
| 2006 | 1.13x | CN¥50.72 Million | CN¥44.86 Million | ▲ +184.6% |
| 2005 | -1.34x | CN¥-108.87 Million | CN¥81.50 Million | ▼ -223.1% |
| 2004 | 1.08x | CN¥110.30 Million | CN¥101.68 Million | ▲ +115.2% |
| 2003 | 0.50x | CN¥45.77 Million | CN¥90.81 Million | ▲ +2.5% |
| 2002 | 0.49x | CN¥45.28 Million | CN¥92.08 Million | ▼ -48.4% |
| 2001 | 0.95x | CN¥71.87 Million | CN¥75.38 Million | ▲ +52.3% |
| 2000 | 0.63x | CN¥41.06 Million | CN¥65.58 Million | — |